| 1. Confirm that the sterilization method is appropriate for the implant |
Check whether the selected method is compatible with the implant material, packaging, coatings, lubricants, electronics, porous structures, and any residual-processing risks.
|
ISO 17665 for moist heat; ISO 11135 for ethylene oxide; ISO 11137 series for radiation; ISO 14937 for general requirements for sterilizing agents; ISO 22441 for vaporized hydrogen peroxide processes.
|
Approved sterilization specification, material compatibility assessment, product drawings, packaging configuration, and documented risk analysis.
|
Verify that the sterilizer is qualified for the process type and load configuration. Confirm calibrated temperature, pressure, humidity, gas or radiation monitoring, and alarm systems where applicable.
|
No unresolved material degradation, coating damage, dimensional change, corrosion, toxic residue, or packaging failure after sterilization and ageing studies.
|
| 2. Verify that the process has been formally validated |
Confirm that validation covers installation qualification, operational qualification, and performance qualification, including the most difficult or worst-case product and load.
|
ISO 11135, ISO 17665, ISO 11137, or ISO 14937, according to the sterilization technology. ISO 13485 supports documented process control and validation requirements.
|
Approved validation protocol and report, defined acceptance criteria, thermocouple or sensor mapping, load diagrams, challenge locations, deviation records, and requalification schedule.
|
Check chamber uniformity, sensor accuracy, cycle recipes, software access control, preventive maintenance, and calibration status before relying on production results.
|
All predefined cycle parameters and performance requirements are met at identified worst-case locations; deviations are investigated and approved before release.
|
| 3. Check the microbiological challenge and sterility assurance approach |
Review bioburden characterization, biological indicator strategy, process challenge devices, sterility testing, and the established sterility assurance level.
|
ISO 11737-1 for bioburden, ISO 11737-2 for sterility tests performed during validation, ISO 11138 for biological indicators, and ISO 14937 or the applicable process-specific standard.
|
Product bioburden trend data, organism identification when required, biological indicator certificates, inoculated challenge results, sterility-test records, and defined recovery methods.
|
Use biological indicators suitable for the sterilization method and place them at locations representing the greatest process resistance. Confirm incubator qualification and control records.
|
The validated process achieves the documented sterility assurance objective, commonly an SAL of 10-6 for terminally sterilized health-care products where justified by the applicable requirements.
|
| 4. Verify routine monitoring and release controls |
Ensure every production cycle is monitored using physical measurements and, where required, chemical or biological indicators. Confirm that release decisions are documented.
|
ISO 11140 series for chemical indicators, ISO 11138 series for biological indicators, and the applicable sterilization-process standard.
|
Complete cycle printouts or electronic records, indicator results, load identification, operator review, release authorization, nonconformance reports, and corrective-action records.
|
Confirm traceable calibration of sensors and recorders. Verify that failed alarms, incomplete cycles, power interruptions, and out-of-tolerance conditions automatically trigger investigation or hold status.
|
No product is released when critical parameters, indicator results, packaging integrity, or required documentation fail to meet the approved specification.
|
| 5. Review packaging integrity, residuals, and ongoing requalification |
Confirm that the sterile barrier system protects the implant through sterilization, handling, transport, storage, and the labeled shelf life.
|
ISO 11607-1 and ISO 11607-2 for packaging systems for terminally sterilized medical devices; ISO 10993-7 may apply to ethylene oxide residuals.
|
Seal-strength and integrity tests, distribution simulation, accelerated or real-time ageing data, environmental conditioning, residual testing where applicable, and complaint or trend reviews.
|
Check sealing equipment settings, seal-jaw temperature and pressure, package inspection controls, storage conditions, and scheduled equipment maintenance.
|
Sterile barrier integrity remains acceptable after validated ageing and distribution challenges; residuals meet applicable limits; requalification is completed after significant changes or at the defined interval.
|